|
COMMD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.47830020131346E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
1.684840E-01 |
| Stage1-vs-Stage3 |
1.141400E-01 |
| Stage1-vs-Stage4 |
7.56259999999953E-05 |
| Stage2-vs-Stage3 |
3.364300E-02 |
| Stage2-vs-Stage4 |
1.223180E-04 |
| Stage3-vs-Stage4 |
1.711630E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.41420003380222E-10 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
8.803600E-01 |
| Caucasian-vs-Asian |
8.107200E-01 |
| AfricanAmerican-vs-Asian |
7.978400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.564100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.380770E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.044200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.402400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.178600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.308000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.055200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.951400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.795700E-02 |
| Classical-VS-Follicular |
1.78238999999358E-05 |
| Classical-VS-Other |
5.548800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.75670000002182E-06 |
| Tall-VS-Other |
6.364200E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
6.689700E-02 |
| Follicular-VS-Normal |
1.08300000078998E-08 |
| Other-VS-Normal |
4.34219999956298E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.196470E-04 |
|
|
